Advertisement

Topics

Melinta’s Baxdela FDA approved

11:30 EDT 21 Jun 2017 | CentreWatch

Melinta Therapeutics, a privately held company focused on discovering, developing, and commercializing novel antibiotics to treat serious bacterial infections, has announced that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. Baxdela is a […]

The post Melinta’s Baxdela FDA approved appeared first on CenterWatch News Online.

Original Article: Melinta’s Baxdela FDA approved

NEXT ARTICLE

More From BioPortfolio on "Melinta’s Baxdela FDA approved"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...